How Healthcare and Life Science Companies Fail
How Healthcare and Life Science Companies Fail: Understanding the Cascade of Crises and Best Practices for Mitigation
The Slow Evolution of Business Insolvency
Business insolvency is a complex and multi-faceted phenomenon that can halt even the most promising enterprises. In recent years, the healthcare, technology, and life science industries have been particularly vulnerable to this fate, with several high-profile cases illustrating the potential consequences of poor governance and leadership. This article, intended for institutional investors, research analysts, and board members, will provide a comprehensive overview of the stages of business insolvency and explore the best practices for intervention and mitigation at each phase.
I. The Crisis of Governance and Leadership
"The first responsibility of a leader is to define reality. The last is to say thank you. In between, the leader is a servant." - Max De Pree
The first stage of business insolvency often begins with a breakdown in governance and leadership. This can manifest in various ways, such as a lack of vision or strategic direction, poor oversight, and inadequate risk management.
Case Study:
Theranos, a now-defunct health technology company, claimed to have developed a revolutionary blood-testing device. The company faced a crisis of governance and leadership due to its founder and CEO, Elizabeth Holmes, who concealed the device's inefficacy and promoted false claims (Carreyrou, 2018). The lack of transparency and proper oversight led to the company's downfall, with criminal convictions against Holmes and former president Ramesh "Sunny" Balwani (U.S. Department of Justice, 2021).
Best Practices for Mitigation:
Implement robust corporate governance frameworks and policies.
Establish clear roles and responsibilities for board members and executives.
Encourage a culture of transparency and open communication.
Invest in leadership development and training programs.
II. The Crisis of Strategy
"Strategy is about making choices, trade-offs; it's about deliberately choosing to be different." - Michael Porter
A crisis of strategy follows when a company fails to adapt to changing market conditions or loses its competitive edge. This often involves disruptive innovations or regulatory changes in the healthcare, technology, and life science industries.
Case Study:
IBM Watson Health, a division of IBM, aimed to revolutionize healthcare using artificial intelligence (A.I.). However, the company encountered a crisis of strategy when its A.I. platform failed to deliver accurate and actionable insights for cancer treatment (Ross & Swetlitz, 2021). IBM struggled to adapt to the complexities of healthcare and the rapid advancements in A.I., ultimately leading to the sale of Watson Health in 2021 (Finnegan, 2021).
Best Practices for Mitigation:
Regularly review and update strategic plans.
Implement agile methodologies and adopt a culture of innovation.
Leverage data and analytics to inform decision-making.
Engage external consultants for business transformation advising.
III. The Crisis of Profits and Cash Flow
"Cash flow is the lifeblood of business." - Richard Branson
A crisis of profits and cash flow emerges when a company's expenses outpace its revenue, leading to a decline in profitability and, ultimately, a shortage of funds for operations. This is particularly common in industries with high R&D expenses and long product development cycles, such as healthcare and life sciences.
Case Study:
NantHealth, a personalized healthcare company, faced a crisis of profits and cash flow due to high R&D expenses and a slow market adoption of its products (Muoio, 2018). The company experienced declining revenues and mounting losses, leading to staff layoffs and cost-cutting measures (Cohen, 2018). In response, NantHealth divested non-core assets and refocused on its core product offerings to regain financial stability (FierceHealthcare, 2019).
Best Practices for Mitigation:
Implement rigorous financial controls and reporting.
Optimize operational efficiency through process improvements and cost-cutting measures.
Reassess product portfolios and divest non-core assets.
Seek the guidance of business turnaround advisors.
IV. The Crisis of Liquidity and Insolvency
"The worst thing you can do is cling to the past. Address the situation, face the brutal facts, and take action." - Jim Collins
The final stage in the cascade of crises is a liquidity crisis, wherein a company cannot meet its short-term financial obligations. Without timely intervention, this can result in insolvency and potential bankruptcy (Altman, 2013).
Case Study:
Pernix Therapeutics, a specialty pharmaceutical company, found itself in a crisis of liquidity and insolvency due to the mounting debt associated with acquisitions and declining sales of its products (Loftus, 2019). Unable to meet its financial obligations, Pernix filed for bankruptcy in 2019 (Reuters, 2019). The company was then acquired by High Ridge Pharmaceuticals, which sought to maximize the value of Pernix's assets and continue operations (FiercePharma, 2019).
Best Practices for Mitigation:
Develop contingency plans for potential cash flow disruptions.
Engage in proactive stakeholder communication and negotiation.
Seek the assistance of restructuring advisors to develop and implement financial restructuring plans.
Consider strategic partnerships or mergers and acquisitions to create synergies and strengthen the balance sheet.
Crisis Management:
One key to ensuring mitigation success is to establish a formal crisis management team responsible for the following:
Ensure sufficient understanding and appreciation of the evolving crisis: A crisis management team must recognize the signs of a crisis and call attention to it. This enables the organization to respond quickly and proactively to any emerging issues.
Ensure senior leaders are prepared and committed: The crisis management team must have the full support of senior leadership, as their commitment is crucial for the successful execution of any mitigation efforts. This includes allocating necessary resources, setting priorities, and making tough decisions.
Ensure individual initiatives are aligned with a comprehensive crisis management plan: The crisis management team should develop a holistic plan to address the crisis, outlining clear objectives, timelines, and responsibilities. Individual initiatives should align with this plan, ensuring a coordinated approach to crisis management.
Ensure the organization's 'human' element and culture are not lost: Throughout the crisis management process, it is crucial to maintain its culture and values. This can be achieved by fostering open communication, promoting employee engagement, and supporting those impacted by the crisis.
By establishing a formal crisis management team and adhering to these guiding principles, companies can navigate the cascade of crises and mitigate the risks associated with insolvency. This approach allows organizations to emerge from crises stronger and better positioned for future success.
Conclusion
In conclusion, healthcare and life science companies often face a cascade of crises that can lead to insolvency, including breakdowns in governance and leadership, strategy, profits and cash flow, and liquidity. By understanding these stages and implementing best practices at each phase, organizations can mitigate risks and build resilience against insolvency. Establishing a formal crisis management team ensures companies can proactively respond to emerging issues, maintain strong leadership support, align individual initiatives with a comprehensive crisis management plan, and preserve the organization's culture and values. By embracing these principles, healthcare, and life science companies can navigate through turbulent times, ultimately emerging stronger and better positioned for future success.
References:
Altman, E. I. (2013). Corporate Financial Distress, Restructuring, and Bankruptcy: Analyze Leveraged Finance, Distressed Debt, and Bankruptcy. John Wiley & Sons.
Alvarez & Marsal. (2021). Restructuring & Turnaround Services.
Barton, L. (2011). Crisis Leadership Now: A Real-World Guide to Preparing for Threats, Disaster, Sabotage, and Scandal. McGraw Hill Professional.
Cameron, K. S., & Quinn, R. E. (2011). Diagnosing and Changing Organizational Culture: Based on the Competing Values Framework. John Wiley & Sons.
Carreyrou, J. (2018). Bad Blood: Secrets and Lies in a Silicon Valley Startup. Knopf.
Cohen, J. (2018). NantHealth to lay off 300 employees as part of cost-cutting effort. FierceBiotech.
Deloitte. (2021). Turnaround & Restructuring.
Denning, S. (2018). The Age of Agile: How Smart Companies Are Transforming the Way Work Gets Done. Amacom.
Edelman Trust Barometer. (2021). R
EY. (2021). Turnaround and Restructuring Strategy.
FierceHealthcare. (2019). NantHealth sells off home health business in bid for profitability.
FiercePharma. (2019). Bankrupt Pernix Therapeutics sells assets to High Ridge Pharmaceuticals.
Fink, S. (2013). Crisis Management: Planning for the Inevitable. iUniverse.
Finnegan, J. (2021). IBM's Watson Health reportedly on the chopping block. FierceHealthcare.
Grant Thornton. (2021). Corporate Advisory & Restructuring Services.
Harvard Business Review. (2017). What Sets Successful CEOs Apart.
Harvard Business Review. (2019). The Transformation-Ready Business.
Harvard Business Review. (2020). The Leader’s Guide to Corporate Culture.
KPMG. (2021). Turnaround and Restructuring Services.
Loftus, P. (2019). Pernix Therapeutics files for bankruptcy. The Wall Street Journal.
McKinsey. (2021). A framework for resolving corporate crises.
Muoio, D. (2018). NantHealth's struggles continue as Q1 revenue plummets, losses mount. FierceBiotech.
Pearson, C. M., & Clair, J. A. (1998). Reframing Crisis Management. The Academy of Management Review, 23(1), 59-76.
Pisano, G. P. (2015). You Need an Innovation Strategy. Harvard Business Review.
PwC. (2021). Corporate Restructuring & Insolvency.
Reuters. (2019). Drugmaker Pernix Therapeutics files for bankruptcy.
Shechter, D., & Gough, O. (2021). Turnaround Management: Unlocking and Preserving Value in Distressed Businesses. Routledge.
The Economist. (2021). IBM Watson: Not so elementary.